TET2 mutations are associated with aberrant DNA methylation in a wide spectrum of myeloid malignancies, including myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). The gene discussed is TET2; the disease is acute myeloid leukemia.